| XLS |
|
|
|
|
|
|
|
|
€ million |
Land, |
Plant and |
Other facilities, |
Construction |
Total |
|
Acquisition cost January 1, 2010 |
1,894.2 |
2,455.5 |
804.9 |
509.2 |
5,663.8 |
|
Currency translation |
129.1 |
78.1 |
21.9 |
41.6 |
270.7 |
|
Changes in scope of consolidation |
240.5 |
109.4 |
14.6 |
75.8 |
440.3 |
|
Additions |
14.1 |
33.2 |
37.8 |
311.1 |
396.2 |
|
Disposals |
–12.8 |
–76.9 |
–38.8 |
–2.3 |
–130.8 |
|
Transfers |
61.9 |
70.1 |
6.6 |
–155.6 |
–17.0 |
|
Reclassification to assets held for sale |
–5.1 |
–5.5 |
–1.6 |
–0.9 |
–13.1 |
|
December 31, 2010 |
2,321.9 |
2,663.9 |
845.4 |
778.9 |
6,610.1 |
|
|
|
|
|
|
|
|
Accumulated depreciation and impairment losses January 1, 2010 |
–741.3 |
–1,735.9 |
–568.5 |
–10.5 |
–3,056.2 |
|
Currency translation |
–42.9 |
–64.9 |
–17.0 |
– |
–124.8 |
|
Changes in scope of consolidation |
– |
13.9 |
12.7 |
– |
26.6 |
|
Depreciation and impairment losses |
–97.0 |
–177.7 |
–77.0 |
– |
–351.7 |
|
Disposals |
10.5 |
75.3 |
35.4 |
0.4 |
121.6 |
|
Transfers |
–5.1 |
–0.3 |
12.6 |
– |
7.2 |
|
Write-ups |
– |
– |
– |
– |
– |
|
Reclassification to assets held for sale |
3.3 |
4.1 |
1.3 |
– |
8.7 |
|
December 31, 2010 |
–872.5 |
–1,885.5 |
–600.5 |
–10.1 |
–3,368.6 |
|
|
|
|
|
|
|
|
Net carrying amount as of December 31, 2010 |
1,449.4 |
778.4 |
244.9 |
768.8 |
3,241.5 |
|
|
|
|
|
|
|
|
Acquisition cost January 1, 2011 |
2,321.9 |
2,663.9 |
845.4 |
778.9 |
6,610.1 |
|
Currency translation |
27.3 |
3.7 |
3.4 |
–0.6 |
33.8 |
|
Changes in scope of consolidation |
0.6 |
5.1 |
2.5 |
1.1 |
9.3 |
|
Additions |
32.7 |
34.3 |
42.9 |
262.0 |
371.9 |
|
Disposals |
–23.6 |
–41.2 |
–27.7 |
–1.8 |
–94.3 |
|
Transfers |
117.1 |
159.4 |
48.7 |
–310.6 |
14.6 |
|
Reclassification to assets held for sale |
– |
– |
– |
– |
– |
|
December 31, 2011 |
2,476.0 |
2,825.2 |
915.2 |
729.0 |
6,945.4 |
|
|
|
|
|
|
|
|
Accumulated depreciation and impairment losses January 1, 2011 |
–872.5 |
–1,885.5 |
–600.5 |
–10.1 |
–3,368.6 |
|
Currency translation |
–7.4 |
2.1 |
–2.6 |
– |
–7.9 |
|
Changes in scope of consolidation |
2.9 |
– |
– |
– |
2.9 |
|
Depreciation and impairment losses |
–96.2 |
–175.0 |
–85.9 |
–165.1 |
–522.2 |
|
Disposals |
14.8 |
37.0 |
26.3 |
0.9 |
79.0 |
|
Transfers |
3.4 |
–20.2 |
–0.7 |
–0.1 |
–17.6 |
|
Write-ups |
0.8 |
1.4 |
0.2 |
– |
2.4 |
|
Reclassification to assets held for sale |
– |
– |
– |
– |
– |
|
December 31, 2011 |
–954.2 |
–2,040.2 |
–663.2 |
–174.4 |
–3,832.0 |
|
|
|
|
|
|
|
|
Net carrying amount as of December 31, 2011 |
1,521.8 |
785.0 |
252.0 |
554.6 |
3,113.4 |
The changes in scope of consolidation include additions amounting to € 17.4 million (2010: € 474.2 million) and disposals amounting to € 5.2 million (2010: 7.3 million). The additions are due mainly to the acquisition of the microbiology business of Biotest AG. Deconsolidations are due to the divestment of Serono Contracting Ltd., United Kingdom.
Impairment losses totaled € 167.4 million in fiscal 2011. Of this amount, € 165.1 million was attributable to the Large-Scale Biotech (LSB) production facility of the Merck Serono division in Corsier-sur-Vevey, Switzerland and is reported under “Other operating expenses”.
Property, plant and equipment amounting to € 3.2 million served as collateral (2010: € 8.1 million). Total government grants and subsidies during the fiscal year amounted to € 14.8 million (2010: € 11.5 million).
Property, plant and equipment also includes assets that are leased. The total value of capitalized leased assets amounted to € 16.5 million (2010: € 11.6 million) and the corresponding obligations amounted to € 11.8 million (2010: € 7.1 million) (see Note [28]).
The book values of capitalized leased assets were as follows:
| XLS |
|
|
|
|
|
€ million |
Dec. 31, 2011 |
Dec. 31, 2010 |
|
Capitalized leased land and buildings |
14.1 |
9.3 |
|
Capitalized leased vehicles |
1.2 |
2.3 |
|
Capitalized leased other property, plant and equipment |
1.2 |
– |
|
|
16.5 |
11.6 |
back
